Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
15.71%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
CSCIFCompany Name
COSCIENS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOSCIENS BIOPHARMA INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CSCIF - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.48M | 15.71% | $ 9.44M |
| 3/31/2025 | $ 1.57M | 17.42% | $ 9.03M |
| 12/31/2024 | $ 1.61M | 16.76% | $ 9.59M |
| 9/30/2024 | $ 943K | 21.76% | $ 4.33M |
| 6/30/2024 | $ 506K | 20.53% | $ 2.46M |
| 3/31/2024 | $ 173K | 7.29% | $ 2.37M |
| 12/31/2023 | $ 169K | 3.76% | $ 4.5M |
| 9/30/2023 | $ 157K | 2.29% | $ 6.86M |
| 6/30/2023 | $ 148K | 1.7% | $ 8.72M |
| 3/31/2023 | $ 139K | 2.22% | $ 6.25M |
Key Performance Insights, Last 5 Years
- COSCIENS BIOPHARMA INC's latest trailing twelve months (TTM) DepAmor % stands at 19.02%.
- Over the past 5 years, COSCIENS BIOPHARMA INC's average DepAmor % has been 8.01%.
- The median DepAmor % for COSCIENS BIOPHARMA INC during this period was 4.03%
- COSCIENS BIOPHARMA INC reached its highest DepAmor % over the past 5 years at 21.76%.
- The lowest DepAmor % recorded by COSCIENS BIOPHARMA INC in the same timeframe 1.7%
COSCIENS BIOPHARMA INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for COSCIENS BIOPHARMA INC is calculated as follows: DepAmor [ $ 248K ] / Revenues [ $ 1.3M ]
(=) DepAmor % [ 19.02% ] CSCIF - Depreciation and Amortization Margin, Last 5 years
1.7%
Minimum
Jun 30, 2023
21.76%
Maximum
Sep 30, 2024
8.01%
Average
4.03%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |